Q32 Bio (QTTB) Other Non-Current Assets (2017 - 2026)

Q32 Bio (QTTB) recorded quarterly Other Non-Current Assets of $647000.0 in Q1 2026, little changed quarter-over-quarter from $647000.0 in Q4 2025, and little changed on a YoY basis from $647000.0 in Q1 2025.

Q32 Bio (QTTB) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Q32 Bio's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $647000.0 for Q1 2026.

  • In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $647000.0; the TTM figure through Mar 2026 stood at $647000.0 (changed 0.0% YoY), while the FY2025 annual figure was $647000.0, up 457.76% from the prior year.
  • Other Non-Current Assets was $647000.0 for Q1 2026 at Q32 Bio, roughly flat from $647000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $5.6 million in Q1 2023 to a low of $23000.0 in Q4 2023.
  • Historically, Other Non-Current Assets has averaged $1.6 million across 5 years, with a median of $647000.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 1946.01% in 2023, then slumped 99.29% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $276000.0 in 2022, then slumped by 91.67% to $23000.0 in 2023, then jumped by 404.35% to $116000.0 in 2024, then jumped by 457.76% to $647000.0 in 2025, then changed by 0.0% to $647000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $647000.0 (Q1 2026), $647000.0 (Q4 2025), and $647000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Q32 Bio 167.59 Mn 116.84 Mn - 647,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 647,000.00
Dec 31, 2025 647,000.00
Jun 30, 2025 647,000.00
Mar 31, 2025 647,000.00
Dec 31, 2024 116,000.00
Sep 30, 2024 40,000.00
Jun 30, 2024 647,000.00
Mar 31, 2024 647,000.00
Dec 31, 2023 23,000.00
Sep 30, 2023 5.65 Mn
Jun 30, 2023 5.65 Mn
Mar 31, 2023 5.65 Mn
Mar 31, 2022 276,000.00
Dec 31, 2021 1.95 Mn
Sep 30, 2021 1.27 Mn
Jun 30, 2021 1.27 Mn
Mar 31, 2021 1.27 Mn
Dec 31, 2020 1.27 Mn
Sep 30, 2020 1.27 Mn
Jun 30, 2020 1.27 Mn